Skip to content
home button
Search

A primary goal of the ARLG is to train the next generation of researchers who will help reduce the public health threat of antibacterial resistance.

LEARN MORE
search button
  • Home
  • About
    • Thought Leadership
    • Spotlight on Clinical Trial Sites
    • Spotlight on Mentees
    • ARLG Scientific Agenda
  • Publications
  • News and Events
    • Events
    • Newsletters
  • How to Apply
    • Biorepository Request
    • Protocol Concept
    • Early Stage Investigator (ESI) Grants
    • The Dr. John G. Bartlett ARLG Fellowship
    • Clinical Trial Sites
    • Adjudicator Request
    • Industry Collaborations
    • Request Data
  • SDMC
  • Lab Center
    • About the Laboratory Center
    • ARLG Biorepository
    • FAQs
  • Studies
  • Resources
    • For Patients and the Community
    • Summary of Results

ARLG

Antibacterial Resistance Leadership Group

October 2022

Posted on December 13, 2022December 13, 2022 by susan.herron@duke.edu

Our October 2022 newsletter highlights information about IDWeek 2022 including a feature on the Maxwell Finland Lecture by Helen Boucher. We spotlight early stage investigator, Maria Fernanda Mojica, outline ARLG’s helpful data resources, provide updates on the Bartlett Fellowship, and more!

This entry was posted in Newsletter. Bookmark the permalink.

Post navigation

← From Data to Delivery ARLG Has You Covered
Helen Boucher Cites Progress and Perils Fighting Antimicrobial Resistance →
  • Home
  • About the ARLG
  • Publications
  • About the Laboratory Center
  • Studies
ARLG is supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number UM1AI104681. The content of this website is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Subscribe to the ARLG newsletter to stay connected

Contact Us
 
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.